Literature DB >> 8926005

[A prevention program for health problems in the elderly. Ambulatory Geriatric Screening (AGES) for use in general practice].

U Junius1, H Kania, G C Fischer.   

Abstract

Ambulatory Geriatric Screening (AGES) is a standardized interview and examination instrument, the purpose of which is to detect major health or psychosocial problems in the elderly ambulatory patient, and thus prevent secondary illnesses. It comprises a patient and doctor's assistant questionnaire and a doctor's examination sheet with brief instructions for use. In a study conducted between 1992 and 1995, AGES was employed in 67 randomly selected general practitioners' offices in the area around Leipzig and Hannover. An important result was that in an average of 10.2 health-related problems per patient, 4.8, that is almost a half, had been unknown to the care-providing physician. In the case of very old patients, however, the family doctor was usually better informed. The application of the AGES in the office is less time-consuming than might be feared. For the evaluation of the patient questionnaire and the scheduled small examinations, the doctor's assistant needs only 10 to 15 minutes. Thereafter, the family doctor can check the results at a glance and use them as a basis for further talks with the patient and his therapeutic approach.

Entities:  

Mesh:

Year:  1996        PMID: 8926005

Source DB:  PubMed          Journal:  Fortschr Med        ISSN: 0015-8178


  2 in total

1.  [Expectations and attitudes concerning geriatric counseling : Results of a survey among general practitioners and hospital-based providers in two German states].

Authors:  H Burkhardt; C Trojan
Journal:  Z Gerontol Geriatr       Date:  2017-01-31       Impact factor: 1.281

2.  Comprehensive Geriatric Assessment (CGA) in general practice: results from a pilot study in Vorarlberg, Austria.

Authors:  Eva Mann; Michael Koller; Christian Mann; Tischa van der Cammen; Johann Steurer
Journal:  BMC Geriatr       Date:  2004-05-19       Impact factor: 3.921

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.